Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ARMP Armata Pharmaceuticals Inc
- Stocks
- Healthcare
- NYSEAMERICAN: ARMP
Price (delayed)
$1.93
Market cap
$69.85M
P/E Ratio
N/A
Dividend/share
N/A
EPS
$0
Enterprise value
$187.43M
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is
Highlights
Armata Pharmaceuticals's EPS has surged by 100% QoQ and by 100% YoY
The company's net income has surged by 99% YoY and by 98% QoQ
The company's debt fell by 20% YoY but it rose by 6% QoQ
The revenue is down by 19% since the previous quarter but it is up by 13% year-on-year
The company's quick ratio has shrunk by 61% YoY and by 50% QoQ
Key stats
What are the main financial stats of ARMP
Market
Valuations
Earnings
Shares outstanding
36.19M
Market cap
$69.85M
Enterprise value
$187.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
16.6
EV/EBIT
15.49
EV/EBITDA
13.9
EV/Sales
44.54
Revenue
$4.21M
Gross profit
$4.21M
Operating income
-$40.89M
Net income
-$426,000
EBIT
$12.1M
EBITDA
$13.48M
Free cash flow
-$36.28M
Per share
Balance sheet
Liquidity
EPS
$0
EPS diluted
-$0.89
Free cash flow per share
-$1
Book value per share
-$1.49
Revenue per share
$0.12
TBVPS
$2.31
Total assets
$87.25M
Total liabilities
$141.03M
Debt
$134.66M
Equity
-$53.78M
Working capital
-$97.37M
Debt to equity
-2.5
Current ratio
0.12
Quick ratio
0.16
Net debt/EBITDA
8.72
Margins
Efficiency
Dividend
EBITDA margin
320.4%
Gross margin
100%
Net margin
-10.1%
Operating margin
-971.7%
Return on assets
-0.4%
Return on equity
N/A
Return on invested capital
11.3%
Return on capital employed
N/A
Return on sales
287.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARMP stock price
How has the Armata Pharmaceuticals stock price performed over time
Intraday
1.05%
1 week
3.21%
1 month
-14.22%
1 year
-31.8%
YTD
4.32%
QTD
32.19%
Financial performance
How have Armata Pharmaceuticals's revenue and profit performed over time
Revenue
$4.21M
Gross profit
$4.21M
Operating income
-$40.89M
Net income
-$426,000
Gross margin
100%
Net margin
-10.1%
The company's net margin has surged by 100% YoY and by 97% QoQ
The company's net income has surged by 99% YoY and by 98% QoQ
The revenue is down by 19% since the previous quarter but it is up by 13% year-on-year
ARMP's gross profit is down by 19% since the previous quarter but it is up by 13% year-on-year
Price vs fundamentals
How does ARMP's price correlate with its fundamentals
Growth
What is Armata Pharmaceuticals's growth rate over time
Valuation
What is Armata Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
16.6
EV/EBIT
15.49
EV/EBITDA
13.9
EV/Sales
44.54
Armata Pharmaceuticals's EPS has surged by 100% QoQ and by 100% YoY
The equity has contracted by 12% from the previous quarter but it has grown by 4.8% YoY
ARMP's price to sales (P/S) is 89% lower than its 5-year quarterly average of 149.4 and 18% lower than its last 4 quarters average of 20.2
The revenue is down by 19% since the previous quarter but it is up by 13% year-on-year
Efficiency
How efficient is Armata Pharmaceuticals business performance
ARMP's return on invested capital has surged by 122% year-on-year
Armata Pharmaceuticals's return on sales has surged by 114% YoY
Armata Pharmaceuticals's ROA has soared by 99% YoY and by 98% from the previous quarter
Dividends
What is ARMP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARMP.
Financial health
How did Armata Pharmaceuticals financials performed over time
ARMP's total assets is 38% lower than its total liabilities
ARMP's current ratio has dropped by 68% year-on-year and by 48% since the previous quarter
The company's quick ratio has shrunk by 61% YoY and by 50% QoQ
The company's debt fell by 20% YoY but it rose by 6% QoQ
ARMP's debt to equity is up by 16% year-on-year and by 4.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.